Skip to main content

Animations

MJFF Publications

6001 - 6010 of 8825 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2022
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Five-Year Longitudinal Trajectories of Non-Motor Symptoms in Relation to Baseline Dopaminergic Decline in Parkinson’s Disease
    Journal Name: Brain Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dscb.2025.100288
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Lasmiditan ameliorates cortico-hippocampal pathology and improves cognition in aging parkinsonian mice
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2025.115502
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Neural networks reveal novel gene signatures in Parkinson disease from single-nuclei transcriptomes
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-01147-0
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responses
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41531-025-01159-w
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Associations between epilepsy-related polygenic risk and brain morphology in childhood
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awaf259
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Alzheimer’s disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment
    Journal Name: Nature Aging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s43587-022-00290-0
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Multiclass prediction of different dementia syndromes based on multi-centric volumetric MRI imaging
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2023.103320
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Neural correlates of impulse control behaviors in Parkinson’s disease: Analysis of multimodal imaging data
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2023.103315
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Protocol to measure centrosome cohesion deficits mediated by pathogenic LRRK2 in cultured cells using confocal microscopy
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xpro.2022.102024
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Time-resolved RNA signatures of CD4+ T cells in Parkinson’s disease
    Journal Name: Cell Death Discovery
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41420-023-01333-0
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.